BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mollinedo F, Gajate C. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts. J Lipid Res 2020;61:611-35. [PMID: 33715811 DOI: 10.1194/jlr.TR119000439] [Cited by in Crossref: 42] [Cited by in F6Publishing: 72] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Santos-Pereira C, Guedes JP, Ferreira D, Rodrigues LR, Côrte-Real M. Lactoferrin perturbs intracellular trafficking, disrupts cholesterol-rich lipid rafts and inhibits glycolysis of highly metastatic cancer cells harbouring plasmalemmal V-ATPase. Int J Biol Macromol 2022;220:1589-604. [PMID: 36116593 DOI: 10.1016/j.ijbiomac.2022.09.120] [Reference Citation Analysis]
2 Bengoechea-alonso MT, Aldaalis A, Ericsson J. Loss of the Fbw7 tumor suppressor rewires cholesterol metabolism in cancer cells leading to activation of the PI3K-AKT signalling axis. Front Oncol 2022;12:990672. [DOI: 10.3389/fonc.2022.990672] [Reference Citation Analysis]
3 Abdalkareem Jasim S, Kzar HH, Haider Hamad M, Ahmad I, Al-gazally ME, Ziyadullaev S, Sivaraman R, Abed Jawad M, Thaeer Hammid A, Oudaha KH, Karampoor S, Mirzaei R. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update. International Immunopharmacology 2022;110:109074. [DOI: 10.1016/j.intimp.2022.109074] [Reference Citation Analysis]
4 Zhang S, Zhu N, Li HF, Gu J, Zhang CJ, Liao DF, Qin L. The lipid rafts in cancer stem cell: a target to eradicate cancer. Stem Cell Res Ther 2022;13:432. [PMID: 36042526 DOI: 10.1186/s13287-022-03111-8] [Reference Citation Analysis]
5 Roy A, Patra SK. Lipid Raft Facilitated Receptor Organization and Signaling: A Functional Rheostat in Embryonic Development, Stem Cell Biology and Cancer. Stem Cell Rev Rep 2022. [PMID: 35997871 DOI: 10.1007/s12015-022-10448-3] [Reference Citation Analysis]
6 Wang C, Gao M, Gao D, Guo Y, Gao Z, Gao X, Wang J, Qiao M. Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations. Front Pharmacol 2022;13:941270. [DOI: 10.3389/fphar.2022.941270] [Reference Citation Analysis]
7 Mollinedo F, Gajate C. Clusters of apoptotic signaling molecule-enriched rafts, CASMERs: membrane platforms for protein assembly in Fas/CD95 signaling and targets in cancer therapy. Biochem Soc Trans 2022:BST20211115. [PMID: 35587168 DOI: 10.1042/BST20211115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Oberle R, Kührer K, Österreicher T, Weber F, Steinbauer S, Udonta F, Wroblewski M, Ben-Batalla I, Hassl I, Körbelin J, Unseld M, Jauhiainen M, Plochberger B, Röhrl C, Hengstschläger M, Loges S, Stangl H. The HDL particle composition determines its antitumor activity in pancreatic cancer. Life Sci Alliance 2022;5:e202101317. [PMID: 35577388 DOI: 10.26508/lsa.202101317] [Reference Citation Analysis]
9 Wåhlén E, Olsson F, Söderberg O, Lennartsson J, Heldin J. Differential impact of lipid raft depletion on platelet-derived growth factor (PDGF)-induced ERK1/2 MAP-kinase, SRC and AKT signaling. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110356] [Reference Citation Analysis]
10 van den Brand AD, Bajard L, Steffensen I, Brantsæter AL, Dirven HAAM, Louisse J, Peijnenburg A, Ndaw S, Mantovani A, De Santis B, Mengelers MJB. Providing Biological Plausibility for Exposure–Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework. Toxins 2022;14:279. [DOI: 10.3390/toxins14040279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Parshenkov A, Hennet T. Glycosylation-Dependent Induction of Programmed Cell Death in Murine Adenocarcinoma Cells. Front Immunol 2022;13:797759. [PMID: 35222379 DOI: 10.3389/fimmu.2022.797759] [Reference Citation Analysis]
12 Bhangu SK, Fernandes S, Beretta GL, Tinelli S, Cassani M, Radziwon A, Wojnilowicz M, Sarpaki S, Pilatis I, Zaffaroni N, Forte G, Caruso F, Ashokkumar M, Cavalieri F. Transforming the Chemical Structure and Bio-Nano Activity of Doxorubicin by Ultrasound for Selective Killing of Cancer Cells. Adv Mater 2022;34:e2107964. [PMID: 35100658 DOI: 10.1002/adma.202107964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Tsoneva I, Semkova S, Bakalova R, Zhelev Z, Nuss P, Staneva G, Nikolova B. Electroporation, electrochemotherapy and electro-assisted drug delivery in cancer. A state-of-the-art review. Biophysical Chemistry 2022. [DOI: 10.1016/j.bpc.2022.106819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pi M, Kuang H, Yue C, Yang Q, Wu A, Li Y, Assaraf YG, Yang D, Wu S. Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resistance Updates 2022;61:100822. [DOI: 10.1016/j.drup.2022.100822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
15 Krauß D, Fari O, Sibilia M. Lipid Metabolism Interplay in CRC—An Update. Metabolites 2022;12:213. [DOI: 10.3390/metabo12030213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Maltan L, Andova A, Derler I. The Role of Lipids in CRAC Channel Function. Biomolecules 2022;12:352. [DOI: 10.3390/biom12030352] [Reference Citation Analysis]
17 Wen Tan SL, Israeli E, Ericksen RE, Chow PK, Han W. The altered lipidome of hepatocellular carcinoma. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kusowska A, Kubacz M, Krawczyk M, Slusarczyk A, Winiarska M, Bobrowicz M. Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. Int J Mol Sci 2022;23:1501. [PMID: 35163421 DOI: 10.3390/ijms23031501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
20 Biernatowska A, Wójtowicz K, Trombik T, Sikorski AF, Czogalla A. MPP1 Determines the Mobility of Flotillins and Controls the Confinement of Raft-Associated Molecules. Cells 2022;11:311. [DOI: 10.3390/cells11030311] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Pham DV, Park PH. Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming. J Exp Clin Cancer Res 2022;41:9. [PMID: 34986886 DOI: 10.1186/s13046-021-02223-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Li B, Qin Y, Yu X, Xu X, Yu W. Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Cell Prolif 2021;:e13167. [PMID: 34939255 DOI: 10.1111/cpr.13167] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Lorizate M, Terrones O, Nieto-Garai JA, Rojo-Bartolomé I, Ciceri D, Morana O, Olazar-Intxausti J, Arboleya A, Martin A, Szynkiewicz M, Calleja-Felipe M, Bernardino de la Serna J, Contreras FX. Super-Resolution Microscopy Using a Bioorthogonal-Based Cholesterol Probe Provides Unprecedented Capabilities for Imaging Nanoscale Lipid Heterogeneity in Living Cells. Small Methods 2021;5:e2100430. [PMID: 34928061 DOI: 10.1002/smtd.202100430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Nishimura Y, Yamakawa D, Shiromizu T, Inagaki M. Aurora A and AKT Kinase Signaling Associated with Primary Cilia. Cells 2021;10:3602. [PMID: 34944109 DOI: 10.3390/cells10123602] [Reference Citation Analysis]
25 Kawai T, Matsumori N, Otsuka K. Recent advances in microscale separation techniques for lipidome analysis. Analyst 2021;146:7418-30. [PMID: 34787600 DOI: 10.1039/d1an00967b] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Gajate C, Gayet O, Fraunhoffer NA, Iovanna J, Dusetti N, Mollinedo F. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition. Cancers (Basel) 2021;13:6124. [PMID: 34885233 DOI: 10.3390/cancers13236124] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Wang XD, Kim C, Zhang Y, Rindhe S, Cobb MH, Yu Y. Cholesterol Regulates the Tumor Adaptive Resistance to MAPK Pathway Inhibition. J Proteome Res 2021;20:5379-91. [PMID: 34751028 DOI: 10.1021/acs.jproteome.1c00550] [Reference Citation Analysis]
28 Jeong J, Shin JH, Li W, Hong JY, Lim J, Hwang JY, Chung J, Yan Q, Liu Y, Choi J, Wysolmerski J. MAL2 mediates the formation of stable HER2 signaling complexes within lipid raft-rich membrane protrusions in breast cancer cells. Cell Reports 2021;37:110160. [DOI: 10.1016/j.celrep.2021.110160] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Kim DS, Scherer PE. Obesity, Diabetes, and Increased Cancer Progression. Diabetes Metab J 2021;45:799-812. [PMID: 34847640 DOI: 10.4093/dmj.2021.0077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Sasaki D, Kusamori K, Takayama Y, Itakura S, Todo H, Nishikawa M. Development of nanoparticles derived from corn as mass producible bionanoparticles with anticancer activity. Sci Rep 2021;11:22818. [PMID: 34819568 DOI: 10.1038/s41598-021-02241-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Song Y, Liu W, Zhao Y, Zang J, Gao H. Fumonisin B1 exposure induces apoptosis of human kidney tubular epithelial cells through regulating PTEN/PI3K/AKT signaling pathway via disrupting lipid raft formation. Toxicon 2021;204:31-6. [PMID: 34740561 DOI: 10.1016/j.toxicon.2021.10.013] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
32 Abdullah M, Nakamura T, Ferdous T, Gao Y, Chen Y, Zou K, Michikawa M. Cholesterol Regulates Exosome Release in Cultured Astrocytes. Front Immunol 2021;12:722581. [PMID: 34721384 DOI: 10.3389/fimmu.2021.722581] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Zhou P, Shi W, He XY, Du QY, Wang F, Guo J. Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics. Pharm Biol 2021;59:1480-9. [PMID: 34714209 DOI: 10.1080/13880209.2021.1992448] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
34 Xi Y, Yani Z, Jing M, Yinhang W, Xiaohui H, Jing Z, Quan Q, Shuwen H. Mechanisms of induction of tumors by cholesterol and potential therapeutic prospects. Biomed Pharmacother 2021;144:112277. [PMID: 34624674 DOI: 10.1016/j.biopha.2021.112277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Asif K, Memeo L, Palazzolo S, Frión-Herrera Y, Parisi S, Caligiuri I, Canzonieri V, Granchi C, Tuccinardi T, Rizzolio F. STARD3: A Prospective Target for Cancer Therapy. Cancers (Basel) 2021;13:4693. [PMID: 34572920 DOI: 10.3390/cancers13184693] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
36 Yokoyama N, Hanafusa K, Hotta T, Oshima E, Iwabuchi K, Nakayama H. Multiplicity of Glycosphingolipid-Enriched Microdomain-Driven Immune Signaling. Int J Mol Sci 2021;22:9565. [PMID: 34502474 DOI: 10.3390/ijms22179565] [Reference Citation Analysis]
37 Mollinedo F, Gajate C. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer. Cancers (Basel) 2021;13:4173. [PMID: 34439330 DOI: 10.3390/cancers13164173] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
38 Greenlee JD, Lopez-Cavestany M, Ortiz-Otero N, Liu K, Subramanian T, Cagir B, King MR. Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization. Elife 2021;10:e67750. [PMID: 34342264 DOI: 10.7554/eLife.67750] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Yu W, Ying J, Wang X, Liu X, Zhao T, Yoon S, Zheng Q, Fang Y, Yang D, Hua F. The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease. Front Aging Neurosci 2021;13:691230. [PMID: 34349634 DOI: 10.3389/fnagi.2021.691230] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
40 Semkova S, Antov G, Iliev I, Tsoneva I, Lefterov P, Christova N, Nacheva L, Stoineva I, Kabaivanova L, Staneva G, Nikolova B. Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors. Separations 2021;8:92. [DOI: 10.3390/separations8070092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Fritsch J, Särchen V, Schneider-Brachert W. Regulation of Death Receptor Signaling by S-Palmitoylation and Detergent-Resistant Membrane Micro Domains-Greasing the Gears of Extrinsic Cell Death Induction, Survival, and Inflammation. Cancers (Basel) 2021;13:2513. [PMID: 34063813 DOI: 10.3390/cancers13112513] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Chang JG, Tien N, Chang YC, Lin ML, Chen SS. Oxidative Stress-Induced Unscheduled CDK1-Cyclin B1 Activity Impairs ER-Mitochondria-Mediated Bioenergetic Metabolism. Cells 2021;10:1280. [PMID: 34064109 DOI: 10.3390/cells10061280] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Mollinedo F, Gajate C. Mitochondrial Targeting Involving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine. Pharmaceutics 2021;13:763. [PMID: 34065546 DOI: 10.3390/pharmaceutics13050763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
44 Vona R, Iessi E, Matarrese P. Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity? Front Cell Dev Biol 2021;9:622908. [PMID: 33816471 DOI: 10.3389/fcell.2021.622908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
45 Codini M, Garcia-Gil M, Albi E. Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer. Int J Mol Sci 2021;22:E726. [PMID: 33450869 DOI: 10.3390/ijms22020726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
46 Taleski G, Schuhmacher D, Su H, Sontag JM, Sontag E. Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation. J Biol Chem 2021;296:100237. [PMID: 33380425 DOI: 10.1074/jbc.RA120.016069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Pellerin L, Carrié L, Dufau C, Nieto L, Ségui B, Levade T, Riond J, Andrieu-Abadie N. Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers (Basel) 2020;12:E3147. [PMID: 33121001 DOI: 10.3390/cancers12113147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
48 Ha NT, Lee CH. Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments. Cells 2020;9:E2352. [PMID: 33113804 DOI: 10.3390/cells9112352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
49 Fujimura A, Yasui S, Igawa K, Ueda A, Watanabe K, Hanafusa T, Ichikawa Y, Yoshihashi S, Tsuchida K, Kamiya A, Furuya S. In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy. Cells 2020;9:E2149. [PMID: 32977522 DOI: 10.3390/cells9102149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
50 Ferreri C, Sansone A, Ferreri R, Amézaga J, Tueros I. Fatty Acids and Membrane Lipidomics in Oncology: A Cross-Road of Nutritional, Signaling and Metabolic Pathways. Metabolites 2020;10:E345. [PMID: 32854444 DOI: 10.3390/metabo10090345] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
51 Wu CW, Wang SG, Lee CH, Chan WL, Lin ML, Chen SS. Enforced C-Src Activation Causes Compartmental Dysregulation of PI3K and PTEN Molecules in Lipid Rafts of Tongue Squamous Carcinoma Cells by Attenuating Rac1-Akt-GLUT-1-Mediated Sphingolipid Synthesis. Int J Mol Sci 2020;21:E5812. [PMID: 32823607 DOI: 10.3390/ijms21165812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Szlasa W, Zendran I, Zalesińska A, Tarek M, Kulbacka J. Lipid composition of the cancer cell membrane. J Bioenerg Biomembr 2020;52:321-42. [PMID: 32715369 DOI: 10.1007/s10863-020-09846-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
53 Ediriweera MK, Moon JY, Nguyen YT, Cho SK. 10-Gingerol Targets Lipid Rafts Associated PI3K/Akt Signaling in Radio-Resistant Triple Negative Breast Cancer Cells. Molecules 2020;25:E3164. [PMID: 32664351 DOI: 10.3390/molecules25143164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
54 Kara S, Amon L, Lühr JJ, Nimmerjahn F, Dudziak D, Lux A. Impact of Plasma Membrane Domains on IgG Fc Receptor Function. Front Immunol 2020;11:1320. [PMID: 32714325 DOI: 10.3389/fimmu.2020.01320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
55 Martellucci S, Santacroce C, Santilli F, Manganelli V, Sorice M, Mattei V. Prion Protein in Stem Cells: A Lipid Raft Component Involved in the Cellular Differentiation Process. Int J Mol Sci 2020;21:E4168. [PMID: 32545192 DOI: 10.3390/ijms21114168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
56 Hughes RM, Virag JAI. Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications. Pharmaceuticals (Basel) 2020;13:E112. [PMID: 32492868 DOI: 10.3390/ph13060112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Kadokawa H. Discovery of new receptors regulating luteinizing hormone and follicle-stimulating hormone secretion by bovine gonadotrophs to explore a new paradigm for mechanisms regulating reproduction. J Reprod Dev 2020;66:291-7. [PMID: 32249236 DOI: 10.1262/jrd.2020-012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
58 Sviridov D, Mukhamedova N, Miller YI. Lipid rafts as a therapeutic target. J Lipid Res 2020;61:687-95. [PMID: 32205411 DOI: 10.1194/jlr.TR120000658] [Cited by in Crossref: 17] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]